Description
Tirzepatide 5 mg is a premium-grade lyophilized investigational peptide supplied in a sterile sealed glass vial containing 5 milligrams per unit. This compound belongs to a new class of dual incretin receptor agonists designed to activate both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.
Due to its dual-pathway receptor activity, Tirzepatide has gained significant attention in metabolic and endocrinology research. By targeting two complementary incretin pathways, it is being investigated for coordinated metabolic signaling effects in controlled laboratory environments.
This product is strictly intended for research purposes only and is not approved for human or clinical use.
Mechanism of Action
Tirzepatide is engineered to activate:
• GLP-1 receptors
• GIP receptors
The dual-agonist mechanism is being studied for its influence on metabolic signaling pathways and endocrine regulation models. Compared to single GLP-1 receptor agonists, dual receptor activation is under investigation for potential synergistic interactions in research settings.
Research Applications
Tirzepatide 5 mg is commonly used in laboratory research environments focusing on:
• Metabolic regulation models
• Glucose metabolism research
• Hormonal signaling pathway studies
• Energy balance investigations
• Insulin sensitivity analysis
• Obesity-related metabolic pathway research
• Comparative incretin receptor studies
• Dose-response laboratory evaluations
The compound is particularly relevant for research institutions exploring advanced incretin-based peptide mechanisms.
Scientific Context
Dual incretin receptor agonists represent a significant advancement in peptide-based metabolic research. Ongoing preclinical and clinical investigations have increased scientific interest in receptor co-activation strategies and their impact on metabolic pathway modulation.
Tirzepatide is frequently referenced in research examining next-generation incretin signaling compounds and dual receptor activation models.
Product Specifications
Product Name: Tirzepatide
Content: 5 mg per vial
Form: Lyophilized powder
Grade: Research use only
Purity: High laboratory-grade purity
Packaging: Sterile sealed glass vial
Storage: Store refrigerated at 2–8°C
Stability and Handling
The lyophilized format supports stability under appropriate refrigerated storage conditions.
Recommended laboratory handling:
• Store at 2–8°C
• Protect from light and moisture
• Avoid repeated freeze–thaw cycles
• Reconstitute under sterile laboratory conditions
Proper peptide handling helps preserve structural integrity and ensures reliable experimental outcomes.
Research Classification
Tirzepatide is classified as an investigational peptide compound intended exclusively for:
• In vitro laboratory research
• Analytical testing
• Scientific experimentation
• Controlled research applications
This product is not approved for therapeutic, diagnostic, veterinary, or human use.
Important Notice
This product is sold strictly for laboratory research purposes only.
It is not intended for human consumption, medical use, or clinical application. By purchasing this product, the buyer confirms that it will be used solely for lawful scientific research.
